Meeting
2016 ASCO Annual Meeting
Somatic alterations in the PTEN-PI3K-AKT-mTOR pathway in a cohort of 379 ovarian cancer patients.
Authors
Elizabeth Stover
Dana-Farber Cancer Institute, Boston, MA
Elizabeth Stover , Levi A. Garraway , Ursula A. Matulonis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5572)
DOI
10.1200/JCO.2016.34.15_suppl.5572
Abstract #
5572
Poster Bd #
395
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Incidence of PI3K pathway aberrations and their impact on response to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC) subtypes.
First Author: Reva K Basho
Poster
2017 ASCO Annual Meeting
Pathogenic variants in DNA damage response (DDR) genes in patients with advanced solid tumors.
First Author: Ecaterina Elena Ileana Dumbrava
Poster
2015 ASCO Annual Meeting
Next-generation sequencing to reveal somatic mutations that confer sensitivity to everolimus.
First Author: Sun Min Lim
Poster
2015 ASCO Annual Meeting
Genomic profiling of large-cell neuroendocrine carcinoma of the lung.
First Author: Tomohiro Miyoshi